BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/1/2021 12:36:04 PM | Browse: 444 | Download: 836
 |
Received |
|
2020-09-17 15:42 |
|
Peer-Review Started |
|
2020-09-17 15:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-10-18 17:34 |
|
Revised |
|
2020-10-30 16:00 |
|
Second Decision |
|
2020-11-11 12:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-11-12 20:24 |
|
Articles in Press |
|
2020-11-12 20:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-20 09:01 |
|
Typeset the Manuscript |
|
2020-12-11 13:34 |
|
Publish the Manuscript Online |
|
2021-01-01 12:36 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Retrospective Study |
| Article Title |
Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yu-Ling Lu, Szu-Tah Chen, Tsung-Ying Ho, Wen-Hui Chan, Richard J Wong, Chuen Hsueh and Shu-Fu Lin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chang Gung Memorial Hospital |
CMRPG3J0471 |
| US NIH/NCI Cancer Center Support Grant |
P30 CA008748 |
|
| Corresponding Author |
Shu-Fu Lin, MD, Doctor, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, No. 2 Jingcheng Road, New Taipei City 236, Taiwan. mmg@cgmh.org.tw |
| Key Words |
Lung cancer; Radioiodine; Thyroid cancer; Adenocarcinoma; Sodium/iodide symporter |
| Core Tip |
Radioiodine (RAI) scan is usually performed to detect the existence of differentiated thyroid cancer (DTC). A proportion of lung cancers demonstrate sodium/iodide symporter (NIS) expression. Lung cancers with NIS expression may be able to uptake RAI and show RAI-avid lesions on RAI scan, leading to misinterpretation upon performing this test for DTC surveillance. Single-photon emission computed tomography/computed tomography provides morphologic characterization of the functional tumor, improving diagnostic accuracy over RAI scan. |
| Publish Date |
2021-01-01 12:36 |
| Citation |
Lu YL, Chen ST, Ho TY, Chan WH, Wong RJ, Hsueh C, Lin SF. Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study. World J Clin Cases 2021; 9(1): 71-80 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i1/71.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i1.71 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
